Precigen announces FDA approval of PAPZIMEOS (no further details)

PRECIGEN, INC.

US FDA approval of PAPZIMEOS announced via slide deck at August 18, 2025 investor webcast.
No additional specifics such as indication or market size provided in this filing.
The approval represents a significant regulatory milestone for Precigen (PGEN).

item 7.01 item 9.01

PRECIGEN, INC. filing history →

Source: SEC EDGAR

accession 0001104659-25-079497

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.